Tempus AI announced that 18 abstracts, including one oral presentation, have been accepted for presentation at the American Association for Cancer Research (AACR) Annual Meeting 2025. The event is scheduled to take place from April 25-30 in Chicago.
Tempus researchers will showcase scientific and clinical research highlighting the transformative impact of AI on oncology treatment and patient outcomes. This comprehensive collection of research underscores the utility of Tempus’s multimodal dataset and AI-enabled diagnostic solutions in cancer research.
AACR serves as a leading forum for cancer research, and Tempus looks forward to presenting its findings alongside collaborators in its home city of Chicago. This significant presence demonstrates Tempus's ongoing commitment to advancing precision oncology.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.